{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:24Z","timestamp":1792784184130,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003345","name":"CAMS","doi-asserted-by":"crossref","award":["2016-I2M-1-019"],"award-info":[{"award-number":["2016-I2M-1-019"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Project of Yunnan Province","award":["2019FB045"],"award-info":[{"award-number":["2019FB045"]}]},{"name":"Science and Technology Project of Yunnan Province","award":["2016FA049"],"award-info":[{"award-number":["2016FA049"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773270"],"award-info":[{"award-number":["81773270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jconrel.2019.11.017","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T11:59:34Z","timestamp":1573819174000},"page":"1-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":166,"special_numbering":"C","title":["Development of novel nanoantibiotics using an outer membrane vesicle-based drug efflux mechanism"],"prefix":"10.1016","volume":"317","author":[{"given":"Weiwei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangqun","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.11.017_bb0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00003246-200102000-00030","article-title":"Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock","volume":"29","author":"Joukhadar","year":"2001","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0010","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/jamainternmed.2017.1938","article-title":"Association of adverse events with antibiotic use in hospitalized patients","volume":"177","author":"Tamma","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1529-8019.2012.01494.x","article-title":"Cutaneous and systemic adverse reactions to antibiotics","volume":"25","author":"Diaz","year":"2012","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1517\/17425255.2014.970166","article-title":"Safety issues and drug-drug interactions with commonly used quinolones","volume":"11","author":"Douros","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/phar.1761","article-title":"Fluoroquinolone-associated tendinopathy: does levofloxacin pose the greatest risk?","volume":"36","author":"Bidell","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2015.10.005","article-title":"Controlled drug delivery: historical perspective for the next generation","volume":"219","author":"Yun","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0035","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/nnm.13.118","article-title":"Current trends in the use of liposomes for tumor targeting","volume":"8","author":"Deshpande","year":"2013","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0040","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.msec.2016.11.073","article-title":"Liposome-based drug co-delivery systems in cancer cells","volume":"71","author":"Zununi Vahed","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2009.11.033","article-title":"Liposomes as delivery systems for antibiotics","volume":"387","author":"Drulis-Kawa","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0055","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01295-19","article-title":"Cryo-Electron microscopy structure of an Acinetobacter baumannii multidrug efflux pump","volume":"10","author":"Su","year":"2019","journal-title":"MBio"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0060","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/35016007","article-title":"Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export","volume":"405","author":"Koronakis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10512-6","article-title":"In situ structure and assembly of the multidrug efflux pump AcrAB-TolC","volume":"10","author":"Shi","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1469-0691.2004.00763.x","article-title":"Efflux-mediated multiresistance in gram-negative bacteria","volume":"10","author":"Poole","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0075","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0080","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nature03925","article-title":"Membrane vesicles traffic signals and facilitate group activities in a prokaryote","volume":"437","author":"Mashburn","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40265-013-0155-7","article-title":"A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program","volume":"74","author":"O'Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0090","article-title":"Bacterial outer membrane vesicles suppress tumor by interferon-gamma-mediated antitumor response","volume":"8","author":"Kim","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0095","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2018.09.030","article-title":"A. Goes, R. Garcia, F. Panter, M. Koch, R. Muller, K. Fuhrmann, G. Fuhrmann, biocompatible bacteria-derived vesicles show inherent antimicrobial activity","volume":"290","author":"Schulz","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jmb.2008.03.076","article-title":"Engineered bacterial outer membrane vesicles with enhanced functionality","volume":"380","author":"Kim","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0105","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.0805532107","article-title":"Delivery of foreign antigens by engineered outer membrane vesicle vaccines","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0110","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/nn405724x","article-title":"Bioengineered bacterial outer membrane vesicles as cell-specific drug-delivery vehicles for cancer therapy","volume":"8","author":"Gujrati","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0115","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrmicro3525","article-title":"Outer-membrane vesicles from gram-negative bacteria: biogenesis and functions","volume":"13","author":"Schwechheimer","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0120","first-page":"1","article-title":"Efficacy of a multispecies probiotic as adjunctive therapy in generalized anxiety disorder: a double blind, randomized, placebo-controlled trial","author":"Eskandarzadeh","year":"2019","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0125","article-title":"Identification of the general stress stimulon related to colonization in enterococcus faecalis","author":"Salze","year":"2019","journal-title":"Arch. Microbiol."},{"issue":"5","key":"10.1016\/j.jconrel.2019.11.017_bb0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijantimicag.2019.06.002","article-title":"Synergistic activities of clofazimine with moxifloxacin or capreomycin against mycobacterium tuberculosis in China","volume":"54","author":"Li","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0135","article-title":"Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0140","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biomaterials.2018.02.034","article-title":"Polymeric nanoparticles encapsulating novel TLR7\/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy","volume":"164","author":"Kim","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0145","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1038\/leu.2017.143","article-title":"Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches","volume":"31","author":"Pearson","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0150","article-title":"Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0155","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.celrep.2019.03.054","article-title":"Butyrate protects mice from Clostridium difficile-induced colitis through an HIF-1-dependent mechanism","volume":"27","author":"Fachi","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0160","article-title":"Identification and characterization of human monoclonal antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli infection","volume":"86","author":"Giuntini","year":"2018","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0165","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.biomaterials.2016.10.037","article-title":"Bacterial protoplast-derived nanovesicles for tumor targeted delivery of chemotherapeutics","volume":"113","author":"Kim","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0170","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1292\/jvms.12-0304","article-title":"Histopathological studies on cases of chronic mouse hepatitis by natural helicobacter infections","volume":"75","author":"Nam","year":"2013","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0175","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1093\/gbe\/evx210","article-title":"Preterm infant-associated Clostridium tertium, Clostridium cadaveris, and Clostridium paraputrificum strains: genomic and evolutionary insights","volume":"9","author":"Kiu","year":"2017","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/00365521.2017.1291719","article-title":"Drug-induced liver injury due to antibiotics","volume":"52","author":"Bjornsson","year":"2017","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0185","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1574-6976.2011.00289.x","article-title":"Persistence of antibiotic resistance in bacterial populations","volume":"35","author":"Andersson","year":"2011","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0190","first-page":"218","article-title":"Cellular pharmacodynamics and pharmacokinetics of antibiotics: current views and perspectives","volume":"9","author":"Van Bambeke","year":"2006","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0195","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cell.2016.04.015","article-title":"Bacterial outer membrane vesicles mediate cytosolic localization of LPS and Caspase-11 activation","volume":"165","author":"Vanaja","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/acsinfecdis.8b00212","article-title":"Kill the real with the fake: eliminate intracellular Staphylococcus aureus using nanoparticle coated with its extracellular vesicle membrane as active-targeting drug carrier","volume":"5","author":"Gao","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0205","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.7150\/thno.34837","article-title":"Homotypic cell membrane-cloaked biomimetic Nanocarrier for the targeted chemotherapy of hepatocellular carcinoma","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0210","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2018.08.033","article-title":"Bioinspired and biomimetic systems for advanced drug and gene delivery","volume":"287","author":"Sabu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2019.09.021","article-title":"Bacterial membrane vesicles as promising vaccine candidates","volume":"145","author":"Jiang","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0220","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1099\/mic.0.079400-0","article-title":"Biogenesis and multifaceted roles of outer membrane vesicles from gram-negative bacteria","volume":"160","author":"Kulkarni","year":"2014","journal-title":"Microbiology"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1574-6976.2012.00344.x","article-title":"Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models","volume":"37","author":"McConnell","year":"2013","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/500202","article-title":"The epidemiology and control of Acinetobacter baumannii in health care facilities","volume":"42","author":"Fournier","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0235","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0240","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0245","doi-asserted-by":"crossref","first-page":"402919","DOI":"10.1100\/2012\/402919","article-title":"Vesiculation from Pseudomonas aeruginosa under SOS","volume":"2012","author":"Maredia","year":"2012","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0250","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/1471-2180-11-258","article-title":"Contribution of bacterial outer membrane vesicles to innate bacterial defense","volume":"11","author":"Manning","year":"2011","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0255","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1128\/CMR.00043-12","article-title":"Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance","volume":"25","author":"Fernandez","year":"2012","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0260","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micres.2015.07.008","article-title":"Protective role of E. coli outer membrane vesicles against antibiotics","volume":"181","author":"Kulkarni","year":"2015","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0270","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2016.07.016","article-title":"Solubility, lipophilicity and membrane permeability of some fluoroquinolone antimicrobials","volume":"93","author":"Blokhina","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0275","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0280","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1128\/JB.180.20.5478-5483.1998","article-title":"Gram-negative bacteria produce membrane vesicles which are capable of killing other bacteria","volume":"180","author":"Li","year":"1998","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0285","article-title":"B cell activation by outer membrane vesicles - a novel virulence mechanism","volume":"6","author":"Vidakovics","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jphotobiol.2017.11.011","article-title":"Development of photoprotective, antiphototoxic, and antiphotogenotoxic formulations of ocular drugs with fluoroquinolones","volume":"178","author":"Zgadzaj","year":"2018","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0295","doi-asserted-by":"crossref","DOI":"10.1186\/s12014-018-9204-2","article-title":"Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, Acinetobacter baumannii DU202","volume":"15","author":"Yun","year":"2018","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and immunomodulatory roles of bacterial outer membrane vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0305","first-page":"758","article-title":"Vesicles-mediated resistance to antibiotics in bacteria","volume":"6","author":"Chattopadhyay","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00937-17","article-title":"Antibiotic-mediated modulations of outer membrane vesicles in Enterohemorrhagic Escherichia coli O104:H4 and O157:H7","volume":"61","author":"Bauwens","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0315","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3389\/fmicb.2018.00783","article-title":"Outer membrane vesicles: current status and future direction of these novel vaccine adjuvants","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0320","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.vaccine.2007.01.023","article-title":"Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand","volume":"25","author":"Oster","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0325","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09034-y","article-title":"Bioengineered bacterial vesicles as biological nano-heaters for optoacoustic imaging","volume":"10","author":"Gujrati","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0330","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chom.2012.08.004","article-title":"Outer membrane vesicles of a human commensal mediate immune regulation and disease protection","volume":"12","author":"Shen","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206324","article-title":"Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens","volume":"13","author":"Alkie","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0340","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/187221110791185015","article-title":"Mucosal delivery of vaccines: role of mucoadhesive\/biodegradable polymers","volume":"4","author":"NK","year":"2010","journal-title":"Recent Patents Drug Deliv. Formulat."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0345","article-title":"Rationally designed self-assembling nanoparticles to overcome mucus and epithelium transport barriers for Oral vaccines against helicobacter pylori","volume":"28","author":"Zhang","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0350","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","article-title":"V.d.M. R, F. MHAM, H. HFG, v.B.E.H. PMP, V. P, S. RM, PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time","volume":"224","author":"SAA","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091314","article-title":"Design of outer membrane vesicles as cancer vaccines: a new toolkit for cancer therapy","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0360","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3389\/fimmu.2018.01466","article-title":"Helicobacter pylori outer membrane vesicle size determines their mechanisms of host cell entry and protein content","volume":"9","author":"Turner","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2019.11.017_bb0365","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nature16057","article-title":"Novel antibody-antibiotic conjugate eliminates intracellular S. aureus","volume":"527","author":"Lehar","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.11.017_bb0370","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/cmi.12655","article-title":"Mechanisms of outer membrane vesicle entry into host cells","volume":"18","author":"O\u2019Donoghue","year":"2016","journal-title":"Cell. Microbiol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919306674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919306674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:44:11Z","timestamp":1759160651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919306674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":74,"alternative-id":["S0168365919306674"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.11.017","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel nanoantibiotics using an outer membrane vesicle-based drug efflux mechanism","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}